These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33029136)

  • 1. Organophosphorus Nerve Agents: Types, Toxicity, and Treatments.
    Mukherjee S; Gupta RD
    J Toxicol; 2020; 2020():3007984. PubMed ID: 33029136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
    Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
    Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the development of enzyme-based nerve agent bioscavengers.
    Nachon F; Brazzolotto X; Trovaslet M; Masson P
    Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.
    Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J
    J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
    Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
    Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of catalytic bioscavengers against organophosphorus agents.
    Masson P; Lushchekina SV
    Chem Biol Interact; 2016 Nov; 259(Pt B):319-326. PubMed ID: 26899146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioremediation and bioscavenging for elimination of organophosphorus threats: An approach using enzymatic advancements.
    Jaiswal S; Singh B; Dhingra I; Joshi A; Kodgire P
    Environ Res; 2024 Jul; 252(Pt 2):118888. PubMed ID: 38599448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic bioscavengers against organophosphorus agents: mechanistic issues of self-reactivating cholinesterases.
    Lushchekina S; Masson P
    Toxicology; 2018 Nov; 409():91-102. PubMed ID: 30056174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic bioscavengers in nerve agent poisoning: A promising approach?
    Worek F; Thiermann H; Wille T
    Toxicol Lett; 2016 Feb; 244():143-148. PubMed ID: 26200600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory potency against human acetylcholinesterase and enzymatic hydrolysis of fluorogenic nerve agent mimics by human paraoxonase 1 and squid diisopropyl fluorophosphatase.
    Blum MM; Timperley CM; Williams GR; Thiermann H; Worek F
    Biochemistry; 2008 May; 47(18):5216-24. PubMed ID: 18396898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Organophosphorus poisoning: Towards enzymatic treatments].
    Jacquet P; Poirier L; Daudé D; Chabrière E
    Ann Pharm Fr; 2019 Sep; 77(5):349-362. PubMed ID: 31253354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents.
    Lushchekina SV; Schopfer LM; Grigorenko BL; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
    Front Pharmacol; 2018; 9():211. PubMed ID: 29593539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigation of organophosphorus insecticides from environment: Residual detoxification by bioweapon catalytic scavengers.
    Paidi MK; Satapute P; Haider MS; Udikeri SS; Ramachandra YL; Vo DN; Govarthanan M; Jogaiah S
    Environ Res; 2021 Sep; 200():111368. PubMed ID: 34081974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing organophosphate hydrolase efficacy via protein engineering and immobilization strategies.
    Katyal P; Chu S; Montclare JK
    Ann N Y Acad Sci; 2020 Nov; 1480(1):54-72. PubMed ID: 32814367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversed enantioselectivity of diisopropyl fluorophosphatase against organophosphorus nerve agents by rational design.
    Melzer M; Chen JC; Heidenreich A; Gäb J; Koller M; Kehe K; Blum MM
    J Am Chem Soc; 2009 Dec; 131(47):17226-32. PubMed ID: 19894712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase.
    Ghanem E; Raushel FM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):459-70. PubMed ID: 15982683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic bioscavengers as countermeasures against organophosphate nerve agents.
    Goldsmith M; Ashani Y
    Chem Biol Interact; 2018 Aug; 292():50-64. PubMed ID: 29990481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical Studies on Catalysis Mechanisms of Serum Paraoxonase 1 and Phosphotriesterase Diisopropyl Fluorophosphatase Suggest the Alteration of Substrate Preference from Paraoxonase to DFP.
    Zhang H; Yang L; Ma YY; Zhu C; Lin S; Liao RZ
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29986514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
    Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
    FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.